These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 7424016

  • 1. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H, Stummvoll HK, Kovarik J, Meisinger V, Wolf A, Pinggera WF.
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Level-dependent inhibitory effect of hyperaluminaemia on parathyroid hormone secretion in patients with end-stage renal failure.
    Fernández E, Amoedo ML, Montoliu J.
    Eur J Med; 1992 Dec; 1(8):482-4. PubMed ID: 1341207
    [Abstract] [Full Text] [Related]

  • 4. [Effect on serum aluminium levels of continued ingestion of aluminium gels by patients with chronic renal insufficiency (author's transl)].
    Boukari M, Rottembourg J, Jaudon MC, Clavel JP, Legrain M, Galli A.
    Nouv Presse Med; 1978 Jan 14; 7(2):85-8. PubMed ID: 349501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Desferrioxamine-induced changes of aluminium kinetics during haemodialysis.
    Graf H, Stummvoll HK, Meisinger V.
    Proc Eur Dial Transplant Assoc; 1981 Jan 14; 18():674-80. PubMed ID: 7329995
    [Abstract] [Full Text] [Related]

  • 7. The influence of aluminium on parathyroid hormone levels in haemodialysis patients.
    Cannata JB, Briggs JD, Junor BJ, Beastall G, Fell GS.
    Proc Eur Dial Transplant Assoc; 1983 Jan 14; 19():244-7. PubMed ID: 6878239
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Prolonged and reversible encephalopathy in a chronic haemodialysis patient. Probable responsibility of aluminium salts (author's transl)].
    Buge A, Poisson M, Masson S, Bleibel JM, Lafforgue B, Raymond P, Jaudon MC.
    Nouv Presse Med; 1978 Jun 10; 7(23):2053-9. PubMed ID: 673773
    [Abstract] [Full Text] [Related]

  • 11. Serum aluminium in haemodialysis patients: relation to osteodystrophy, encephalopathy and aluminium hydroxide consumption.
    Heaf JG, Nielsen LP.
    Miner Electrolyte Metab; 1984 Jun 10; 10(6):345-50. PubMed ID: 6503890
    [Abstract] [Full Text] [Related]

  • 12. [Aluminum poisoning in dialysis patients--diagnosis and therapy].
    Vogelsang U.
    Schweiz Rundsch Med Prax; 1994 Jun 14; 83(24):738-56. PubMed ID: 8023059
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effects of zero magnesium dialysate and magnesium supplements on ionised calcium concentration in patients on regular dialysis treatment.
    Breuer J, Moniz C, Baldwin D, Parsons V.
    Nephrol Dial Transplant; 1987 Jun 14; 2(5):347-50. PubMed ID: 3122112
    [Abstract] [Full Text] [Related]

  • 15. [Kinetics of plasma and urine aluminium after renal grafting (author's transl)].
    Hourmant M, Soulillou JP, Boiteau HL, Vecchierini MF, Métayer C, Guénel J.
    Nephrologie; 1981 Jun 14; 2(3):125-9. PubMed ID: 7029337
    [Abstract] [Full Text] [Related]

  • 16. [Spontaneous fracture in a hemodialyzed woman probably associated with the oral intake of aluminium gel (author's transl)].
    Fournier G, Gaillard JL, Bourdon R, Drüeke T.
    Nephrologie; 1981 Jun 14; 2(1):23-6. PubMed ID: 7345373
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide].
    Tahiri Y, Moriniere P, Jaudon MC, Dkhissi H, Rosa A, Fournier A.
    Nephrologie; 1983 Jun 14; 4(3):129-33. PubMed ID: 6633778
    [Abstract] [Full Text] [Related]

  • 19. Bullous dermatosis of end-stage renal disease: a possible association between abnormal porphyrin metabolism and aluminium.
    Gafter U, Mamet R, Korzets A, Malachi T, Schoenfeld N.
    Nephrol Dial Transplant; 1996 Sep 14; 11(9):1787-91. PubMed ID: 8918623
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.